Biologic & Small Molecule NP/PA CME Bootcamp Series

Join Us For up to 8 Hours of Free CME/CE Credit!

Joint Providers

Learning Objectives

  • Describe recent advances in biologic drug development, regulations, and indications in immune-mediated inflammatory diseases (IMIDs), with emphasis on psoriasis, PsA and AD.
  • Critically appraise and discuss relevant evidence on pathophysiology and immunology as applied to psoriasis, psoriatic arthritis and atopic dermatitis.
  • Develop strategies to predict, prevent, and treat potential side effects and complications encountered with biologic agents.
  • Review data regarding associated comorbid conditions associated with psoriasis, PsA, and AD including but not limited to cardiovascular disease, diabetes, obesity, and depression.
  • Analyze recent investigations on safety, efficacy, and toxicity of biologic agents across IMIDs.
  • Through case-based presentation and discussion panels, summarize updates in diagnosis, classification, therapies, and immune-system targets in psoriasis, PsA, and AD and describe their clinical implications.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education, LLC, the Dermatology Education Foundation, and Physician Resources, LLC. Evolve Medical Education, LLC is accredited by the ACCME to provide continuing medical education for physicians.

The DEF Biologic & Small Molecule NP/PA CME Bootcamp Series has two components: Live Activity and Enduring Material.

Evolve Medical Education, LLC designates the live activities for a maximum of 4 AMA PRA Category 1 Credits™. Evolve Medical Education, LLC designates the enduring materials for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PA Continuing Education
PAs may claim a maximum of 8 Category 1 credits for completing the activities. The National Commission on Certification of Physician Assistants (NCCPA) accepts AMA PRA Category 1 Credits from organizations accredited by ACCME or a recognized state medical society.

Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Creditsfrom organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

Faculty Disclosures

  • had relatinshiApril Armstrong has had a financial relationship or affiliation during the past year with the following ineligible companies in the form of: Consultant: Abbvie, Bristol-Myers Squibb, Dermavant, Eli Lilly, Janssen, LEO Pharma, Modernizing Medicine, Novartis AG, Ortho Dermatologics, Pfizer, Inc ., Regeneron Pharmaceuticals, Sanofi Genzyme and Science 37. Grant/Research Support: Abbvie, Bristol-Myers Squibb, Dermira, Eli Lilly, Janssen, Kyowa Hakko Kirin, LEO Pharma, Novartis, Regeneron, Sanofi, and UCB

  • David Cohen, MD, MPH, FAAD has had a financial relationship or affiliation during the past year with the following ineligible companies in the form of: Consultant: Cutanea, Dermavant, Ferndale Laboratories, Ferrer, FIDE and Medimetriks. Stock Shareholder: Brickell Biotech, Kadmon, Dermira, Inc., and Medimetriks.

  • Kara Gooding, MMS, PA-C, has had a financial relationship or affiliation during the past year with the following ineligible companies in the form of Consultant: Janssen, Novartis Pharmaceuticals, Sun Pharma, and UCB. Speaker’s Bureau: Aclaris Therapeutics, Almirall, Celgene, Dermira, LEO Pharma, and Pfizer.

  • Joseph Gorelick, MSN, FNP-C has had a financial relationship or affiliation during the past year with the following ineligible companies in the form of Consultant: AbbVie Pharmaceuticals, Dermira, Lilly, LEO Pharma, Novartis Pharmaceuticals, Ortho Dermatologics, Pfizer, PruGen, Regeneron Pharmaceuticals, Sanofi Genzyme, Sun Pharma, and UCB. Advisory Board/Speaker’s Bureau: AbbVie Pharmaceuticals, Dermira, Lilly, LEO Pharma; Novartis Pharmaceuticals, Ortho Dermatologics, Pfizer, PruGen, Regeneron Pharmaceuticals, Sun Pharma, and UCB.

  • Accreditation and Medical Education Support Disclosure
    • Amber Johnston and Jennifer Hodge of Evolve Medical Education LLC have had no financial relationships or affiliations with ineligible companies.
    • Stacey Moore of Physician Resources, LLC has had no financial relationships or affiliations with ineligible companies.